Novo Nordisk's Diabetes Drug Outshines Ozempic: Buy?
A new diabetes drug from Novo Nordisk could change the GLP-1 landscape. This deep dive breaks down what investors sho...
Explore why new budgets fail and how to prevent it. Learn practical adjustments to build a durable plan that sticks.
26,347 articlesA new diabetes drug from Novo Nordisk could change the GLP-1 landscape. This deep dive breaks down what investors sho...
Dive into how to read myriad genetics (mygn) 2025 earnings transcripts, spot growth drivers, assess risk, and build a...
A prominent Canadian investment firm has disclosed a new stake in Boyd Group Services, highlighting growing interest ...
Lucid fans and skeptics watched the Gravity SUV as a potential turning point. When production snags and a rear-seat r...
Explore the highlights from the (rlx) 2026 earnings call, including what drove revenue, how margins are shaping up, a...
As the EV market accelerates, investors face a key question: which stock—Rivian or Tesla—fits their risk tolerance an...
Karman Holdings stock zoomed more than 6% today as the company was added to a major index. Here’s what happened, why ...
Plug Power stock popped after-hours following a strong Q4 showing and raised 2026 guidance. This article breaks down ...
A standout quarterly report helped Rhythm Pharmaceuticals stock surge on Tuesday as investors embraced better-than-ex...
A sharp move in a little-known mining stock can reshape a small-cap portfolio. Learn why niocorp developments stock p...
Karooooo stock jumped today after a solid earnings report that topped expectations. This article breaks down the numb...
Investors are watching for signs that D-Wave Quantum (QBTS) could follow the stock-split trend set by others. This gu...